Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 4359424, 7 pages
https://doi.org/10.1155/2017/4359424
Research Article

Adverse Pregnancy Outcomes of Patients with History of First-Trimester Recurrent Spontaneous Abortion

1Obstetrics & Gynecology Department, Peking University Third Hospital, Beijing 100191, China
2Obstetrics & Gynecology Department, Peking University International Hospital, Beijing 102206, China

Correspondence should be addressed to Yang-yu Zhao

Received 17 April 2017; Revised 15 June 2017; Accepted 18 June 2017; Published 17 July 2017

Academic Editor: Marco Scioscia

Copyright © 2017 Jing Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Practice Committee of American Society for Reproductive Medicine, “Definitions of infertility and recurrent pregnancy loss: a committee opinion,” Fertility and Sterility, vol. 99, no. 1, article 63, 2013. View at Publisher · View at Google Scholar
  2. J. L. Allison and D. J. Schust, “Recurrent first trimester pregnancy loss: Revised definitions and novel causes,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 16, no. 6, pp. 446–450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Sheiner, A. Levy, M. Katz, and M. Mazor, “Pregnancy outcome following recurrent spontaneous abortions,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 118, no. 1, pp. 61–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Field and D. J. Murphy, “Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study,” Human Reproduction, vol. 30, no. 5, pp. 1239–1245, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Fawzy, S. Saravelos, T. C. Li, and M. Metwally, “Do women with recurrent miscarriage constitute a high-risk obstetric population?” Human Fertility, vol. 19, no. 1, pp. 9–15, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Pijnenborg, L. Vercruysse, and I. Brosens, “Deep placentation,” Best Practice & Research: Clinical Obstetrics & Gynaecology, vol. 25, no. 3, pp. 273–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C. V. Ananth and A. M. Vintzileos, “Ischemic placental disease: epidemiology and risk factors,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 159, no. 1, pp. 77–82, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. R. W. Redline, “Placental pathology: a systematic approach with clinical correlations,” Placenta, vol. 29, pp. S86–S91, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Savchev, F. Figueras, M. Sanz-Cortes et al., “Evaluation of an optimal gestational age cut-off for the definition of early- and late-onset fetal growth restriction,” Fetal Diagnosis and Therapy, vol. 36, no. 2, pp. 99–105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Nawathe and C. Lees, “Early onset fetal growth restriction,” Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 38, pp. 24–37, 2017. View at Google Scholar
  11. J. Gunnarsdottir, O. Stephansson, S. Cnattingius, H. Åkerud, and A.-K. Wikström, “Risk of placental dysfunction disorders after prior miscarriages: a population-based study,” American Journal of Obstetrics and Gynecology, vol. 211, no. 1, pp. 34.e31–34.e38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Whitten, R. Romero, S. J. Korzeniewski et al., “Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): A placental lesion associated with recurrent miscarriage and fetal death,” American Journal of Obstetrics and Gynecology, vol. 208, no. 4, pp. 310–e11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Benton, L. M. McCowan, A. E. P. Heazell et al., “Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction,” Placenta, vol. 42, pp. 1–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Kwiatkowski, B. Dołȩgowska, E. Kwiatkowska, R. Rzepka, A. Torbè, and M. Bednarek-Jȩdrzejek, “A common profile of disordered Angiogenic factor production and the exacerbation of inflammation in early preeclampsia, late preeclampsia, and intrauterine growth restriction,” PLoS ONE, vol. 11, no. 10, Article ID e0165060, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Roberts, “Pathophysiology of ischemic placental disease,” Seminars in Perinatology, vol. 38, no. 3, pp. 139–145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. V. Ananth, “Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption,” Seminars in Perinatology, vol. 38, no. 3, pp. 131-132, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Brosens, R. Pijnenborg, L. Vercruysse, and R. Romero, “The “great Obstetrical Syndromes” are associated with disorders of deep placentation,” American Journal of Obstetrics & Gynecology, vol. 204, no. 3, pp. 193–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Hemberger, “Health during pregnancy and beyond: fetal trophoblast cells as chief co-ordinators of intrauterine growth and reproductive success,” Annals of Medicine, vol. 44, no. 4, pp. 325–337, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. T. Henderson, E. P. Whitlock, E. O'Connor, C. A. Senger, J. H. Thompson, and M. G. Rowland, “Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force,” Annals of Internal Medicine, vol. 160, no. 10, pp. 695–703, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. E. A. Steegers, P. von Dadelszen, J. J. Duvekot, and R. Pijnenborg, “Pre-eclampsia,” The Lancet, vol. 376, no. 9741, pp. 631–644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Rosenberg, G. Pariente, R. Sergienko, A. Wiznitzer, and E. Sheiner, “Critical analysis of risk factors and outcome of placenta previa,” Archives of Gynecology and Obstetrics, vol. 284, no. 1, pp. 47–51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Ying, Y. Lu, Y.-N. Dong, and D.-F. Wang, “Effect of placenta previa on preeclampsia,” PLoS ONE, vol. 11, no. 1, Article ID e0146126, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. I. M. Usta, E. M. Hobeika, A. A. Abu Musa, G. E. Gabriel, and A. H. Nassar, “Placenta previa-accreta: risk factors and complications,” The American Journal of Obstetrics and Gynecology, vol. 193, no. 3, pp. 1045–1049, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Wetta, J. M. Szychowski, S. Seals, M. S. Mancuso, J. R. Biggio, and A. T. N. Tita, “Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery,” American Journal of Obstetrics and Gynecology, vol. 209, no. 1, pp. 51.e51–51.e56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. S. Kramer, C. Berg, H. Abenhaim et al., “Incidence, risk factors, and temporal trends in severe postpartum hemorrhage,” American Journal of Obstetrics and Gynecology, vol. 209, no. 5, pp. 449.e441–449.e447, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Ekin, C. Gezer, U. Solmaz, C. E. Taner, A. Dogan, and M. Ozeren, “Predictors of severity in primary postpartum hemorrhage,” Archives of Gynecology and Obstetrics, vol. 292, no. 6, pp. 1247–1254, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Menten, K. Swerts, B. D. Chiaie et al., “Array comparative genomic hybridization and flow cytometry analysis of spontaneous abortions and mors in utero samples,” BMC Medical Genetics, vol. 10, article no. 1471, p. 89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. E. C. Larsen and O. B. Christiansen, “Recurrent miscarriage - causes, disgnostics and treatment,” Ugeskrift for Laeger, vol. 174, no. 41, pp. 2448–2452, 2012. View at Google Scholar · View at Scopus
  29. R. B. Lathi, F. K. Gray Hazard, A. Heerema-Mckenney, J. Taylor, and J. T. Chueh, “First trimester miscarriage evaluation,” Seminars in Reproductive Medicine, vol. 29, no. 6, pp. 463–469, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. R.-Q. Ma, M.-N. Sun, and Z. Yang, “Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model,” Chinese Medical Journal, vol. 123, no. 6, pp. 707–712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. G. Walker, B. Fitzgerald, S. Keating, J. G. Ray, R. Windrim, and J. C. P. Kingdom, “Sex-specific basis of severe placental dysfunction leading to extreme preterm delivery,” Placenta, vol. 33, no. 7, pp. 568–571, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Romero, J. P. Kusanovic, T. Chaiworapongsa, and S. S. Hassan, “Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae,” Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 25, no. 3, pp. 313–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. R. M. Lewis, J. K. Cleal, and M. A. Hanson, “Review: placenta, evolution and lifelong health,” Placenta, vol. 33, pp. S28–S32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J. N. Bulmer, G. J. Burton, S. Collins et al., “IFPA Meeting 2011 workshop report II: Angiogenic signaling and regulation of fetal endothelial function; Placental and fetal circulation and growth; Spiral artery remodeling,” Placenta, vol. 33, pp. S9–S14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Mitić, A. Novakov Mikić, L. Povazan, A. Mitreski, V. Kopitović, and T. Vejnović, “Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia,” Medicinski Pregled, vol. 64, no. 9-10, pp. 471–475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. M. A. Rodger, M. T. Betancourt, P. Clark et al., “The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies,” PLoS Medicine, vol. 7, no. 6, Article ID e1000292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Kovalevsky, C. R. Gracia, J. A. Berlin, M. D. Sammel, and K. T. Barnhart, “Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis,” Archives of Internal Medicine, vol. 164, no. 5, pp. 558–563, 2004. View at Publisher · View at Google Scholar · View at Scopus